No replies to this topic

[GerryL]

Bone marrow transplants or chemotherapy were once the only treatment options available for chronic myeloid leukemia (CML), a rare blood cancer. Until recently, survival rates weren't remarkable; but new tyrosine kinase inhibitor medications, like imatinib, dasatinib and nilotinib, have transformed CML treatment—patients are now living full lives thanks to targeted therapy. http://www.coloradoc...ent-guidelines/